Last updated on March 2018

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Hereditary Ovarian Cancer Syndrome

Brief description of study

The main objective of the proposed non-interventional study is to obtain real-world effectiveness, safety and treatment patterns data of patients with BRCAm+ (Breast Cancer Gene(s) mutation positive) platinum sensitive relapsed (PSR) ovarian cancer in German hospitals and outpatient practices treated with olaparib.

Clinical Study Identifier: NCT02503436

Contact Investigators or Research Sites near you

Start Over

AstraZeneca Clinical Study Information Center

Research Site
Freiburg im Breisgau, Germany
  Connect »